Impact of Fruit and Vegetables in PKU
Impact of Fruits and Vegetables on Metabolic Control in Children With PKU
1 other identifier
interventional
16
1 country
1
Brief Summary
In the UK, some fruits and vegetables are permitted without measurement in the diets of people with phenylketonuria (PKU). It is proven that fruits and vegetables containing phenylalanine (Phe) up to 75mg/100g (e.g. carrots, sweet potato, tomatoes) do not affect blood Phe control but it is unknown to what extent fruits and vegetables containing Phe from 76-100mg/100g (e.g. cauliflower, broccoli, beansprouts and asparagus) increase blood Phe levels. In addition, there is very little information about how differently animal and vegetable protein affect blood Phe levels. It is believed that plant protein may have less bioavailability and therefore have less impact on blood Phe control. The investigators aim is to perform a randomized controlled study over 21 weeks in children (5-12y) with PKU. Children will be studied during five different time periods, examining the effect on blood Phe control when increasing Phe intake from vegetables/fruits containing Phe from 76-100 mg/100g vs. animal sources. At the end of the study, fruits and vegetables containing 76- 100mg Phe/100g will continue to be given as "exchange-free" for 6 months. This is a practical, cost effective study and should bring benefit to all people with PKU following a very restrictive diet both within the UK and throughout the world.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2019
CompletedFirst Submitted
Initial submission to the registry
June 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2022
CompletedFebruary 21, 2022
February 1, 2022
1.9 years
June 10, 2021
February 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood Phe levels three times a week of patients with PKU taking extra 1 or 2 exchanges of fruits and vegetables containing 76-100mg of Phe/100g during 4 weeks each.
8 weeks
Blood Phe levels three times a week of patients with PKU taking extra 1 or 2 exchanges of animal protein during 4 weeks each.
8 weeks
Secondary Outcomes (1)
Blood Phe levels three times a week with PKU taking fruits and vegetables containing 76-100mg of Phe/100g without measurement during 6 months.
6 months
Study Arms (2)
Group starting intervention with vegetable protein
ACTIVE COMPARATORPhase A followed by Phases B, C, D, E.
Group starting intervention with animal protein
ACTIVE COMPARATORPhase A followed by Phases D, E, B, C.
Interventions
Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt
Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily
Eligibility Criteria
You may qualify if:
- PKU patients diagnosed by NBS and BH4 deficiencies;
- Early and continuously treated;
- Adherent to their prescribed PKU diet consisting of a protein-restricted diet and Phe-free amino acid based protein substitute;
- In good general health as evidenced by medical history;
- Able to provide written informed consent/assent (parent/child);
- Able to comply with the study protocol and take study product according to the opinion of the PI;
- Patients with good metabolic control (age 5-12y, 120-360μmol/L) with 3 out of 4 levels within range prior to consent (if 2 of 4 above target range but one close to the upper limit, PI to decide if patient can enter the study).
You may not qualify if:
- Concomitant diseases / disorders such as renal or gut disease / disorders and diabetes;
- Dislikes fruits and vegetables containing 76-100 mg of Phe/100g e.g.brocolli or cauliflower;
- Treated with BH4 (sapropterin);
- Presence of intercurrent infection;
- Patients with poor metabolic control (age 5-12y, \>360μmol/L).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alex Pintolead
Study Sites (1)
Birmingham Women's and Children's Hospital
Birmingham, West Midlands, B4 6NH, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Dietitian
Study Record Dates
First Submitted
June 10, 2021
First Posted
February 21, 2022
Study Start
July 20, 2019
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
February 21, 2022
Record last verified: 2022-02